Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations and consumer healthcare products primarily in India and internationally. The company develops pharmaceuticals for acute and chronic therapeutics in the areas of anti-infective, cardiovascular, gastrointestinal, anti-diabetic, dermatology, pain/analgesics, neuro/CNS, vitamins/minerals/nutrients, and respiratory diseases. It also provides consumer healthcare products, such as condoms, pregnancy detection kits, emergency contraceptives, antacid powders, vitamin and mineral supplements, and anti-acne preparations. The company offers its products primarily under the Manforce, Prega News, Unwanted-72, Gas-O-Fas, Health OK, and AcneStar brand names. In addition, it engages in the trading and exporting of pharmaceutical and health care products; manufacturing of packing materials ayurvedic products, packing materials, bulk drugs, and consumer goods; real estate, leasing, and hospitality businesses; and provision of IT services. Mankind Pharma Limited was founded in 1986 and is based in New Delhi, India.
Revenue of Mankind Pharma Limited (MANKIND.NS)
Revenue in 2023 (TTM): $1.22 B
According to Mankind Pharma Limited's latest financial reports the company's current revenue (TTM) is $1.22 B. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history of Mankind Pharma Limited
Annual Revenue
| Year | Revenue | Gross Profit | Ebitda | Income Before Tax | Net Income |
|---|---|---|---|---|---|
| 2023 | $1.22 B | $499.38 M | $332.49 M | $283.95 M | $226.38 M |
| 2022 | $1.03 B | $401 M | $239.85 M | $196.31 M | $151.7 M |
| 2021 | $920.91 M | $628.6 M | $254.08 M | $233.69 M | $169.65 M |
| 2020 | $735.45 M | $519.47 M | $214.98 M | $200.2 M | $149.76 M |
| 2019 | $694.13 M | $466.5 M | $182.36 M | $170.15 M | $121.95 M |
| 2018 | $589.36 M | $382.06 M | $110.73 M | $103.51 M | $68.47 M |